Although some patients have persistent symptoms or develop new symptoms following
coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID …

The emergence of persistent ill-health in the aftermath of SARS-CoV-2 infection has
presented significant challenges to patients, healthcare workers and researchers. Termed …

The novel coronavirus disease 19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), can have two phases: acute (generally 4 weeks …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the start of the …

Olfactory dysfunction is one of the long-term consequences of acute SARS-CoV-2 infection
in adults. This study aims to analyze the prevalence of chronic anosmia among COVID-19 …

COVID-19 is associated with a common symptom of olfactory dysfunction, which may persist
even after the infection is resolved. Olfactory training (OT) has emerged as the most effective …

Background: Anosmia is defined as the complete absence of olfactory function, which can
be caused by a variety of causes, with upper respiratory tract infections being among the …

In the majority of cases, patients infected with the SARS-CoV-2 virus experience a complete
resolution of symptoms within six weeks of acquiring the infection, but an increasing number …

COVID-19 is an ongoing global pandemic caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus. Although it primarily attacks the respiratory tract …

Purpose Olfactory dysfunction (OD) is a common presenting sign of coronavirus-19 (COVID-
19) infection and remains persistent in up to 7% of patients one year after diagnosis …